Growth inhibition of Tetrahymena pyriformis by a hypocholesteremic compound and the mechanism of its reversal by various lipids.
D015068:17-Ketosteroids / Q000494:pharmacology; D000736:Androstenes / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D000924:Anticholesteremic Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002784:Cholesterol / Q000494:pharmacology; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D004952:Esters / Q000494:pharmacology; D005019:Ethyl Ethers / Q000494:pharmacology; D006017:Glycolipids / Q000302:isolation & purification / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008055:Lipids / Q000494:pharmacology*; D011083:Polycyclic Compounds / Q000378:metabolism; D012855:Sitosterols / Q000494:pharmacology; D013025:Glycine max / Q000032:analysis; D013261:Sterols / Q000302:isolation & purification / Q000494:pharmacology; D013265:Stigmasterol / Q000494:pharmacology; D013729:Terpenes / Q000378:metabolism; D013769:Tetrahymena pyriformis / Q000187:drug effects / Q000254:growth & development*
D015068:17-Ketosteroids; D000736:Androstenes; D000924:Anticholesteremic Agents; D004952:Esters; D005019:Ethyl Ethers; D006017:Glycolipids; D008055:Lipids; D011083:Polycyclic Compounds; D012855:Sitosterols; D013261:Sterols; D013729:Terpenes; D002784:Cholesterol; D013265:Stigmasterol